Erectile dysfunction decisions — 2025

The Board remands the case to obtain a medical opinion addressing whether the Veteran's erectile dysfunction has been aggravated by his service-connected hypertension.

The Board remands the claims for service connection for erectile dysfunction and macular degeneration as further development is necessary.

The Board denied the veteran's claims for earlier effective dates, increased ratings for diabetes mellitus type II and erectile dysfunction, and a higher rate of special monthly compensation.

The Board denied service connection for erectile dysfunction with hypogonadism, hypertension, and tinnitus due to insufficient evidence of current disability or functional impairment. The claims for these conditions were remanded for further development.

The Board remands the claim for service connection for erectile dysfunction to correct a pre-decisional duty to assist error, specifically scheduling a VA examination.

The Board denied service connection for bilateral hearing loss and remanded the remaining claims for further development.

The Board granted earlier effective dates for service connection and related benefits, including prostate cancer, erectile dysfunction, special monthly compensation, and DEA benefits, all effective May 10, 2022.

The Board granted an initial 10 percent rating for residuals of prostate cancer prior to January 19, 2024, and a 20 percent rating from that date. Service connection was also granted for erectile dysfunction, and special monthly compensation based on loss of use of a creative organ was awarded.

The Veteran's service connection for erectile dysfunction (ED) was granted, while the claims for earlier effective dates and TDIU were denied.

The Board denied service connection for erectile dysfunction as it was not shown to have been incurred in or caused by the Veteran's active service, nor due to a service-connected disability.

The Board denied service connection for multiple conditions, including bilateral hearing loss, cervical stenosis of the spine, acid reflux, erectile dysfunction, and chronic hemorrhoids. The remaining claims for degenerative joint disease in various parts of the body were remanded for further development.

The Board denied service connection for erectile dysfunction, left hand tremor, and right hand tremor as the evidence did not support a current diagnosis of these conditions or a link to the Veteran's active duty service.

The Board denied the veteran's claims for earlier effective dates and increased ratings for various disabilities, including erectile dysfunction as a complication of type II diabetes mellitus.

The Board remands the claims for service connection for nerve pain right lower extremity, erectile dysfunction, and neck pain to obtain a VA examination.

The Board remands the claims for service connection and increased ratings due to outstanding records, TERA compliance, and inadequate VA examinations.

The Board granted service connection for erectile dysfunction and OSA, both considered secondary to the Veteran's service-connected PTSD with MDD.

The Board granted service connection for sleep apnea, diabetes mellitus, type II (DMII), gastroesophageal reflux disease (GERD), hypertension, and erectile dysfunction, all of which are found to be secondary to the Veteran's service-connected musculoskeletal disabilities.

The Board granted service connection for sleep apnea and dismissed the claim for bilateral hearing loss due to a claims processing defect. The appeal was denied for increased ratings of PTSD with depression, erectile dysfunction, and cervical and lumbar spine conditions, while these issues were remanded for further consideration.

The Board granted service connection for erectile dysfunction as secondary to the Veteran's service-connected PTSD, heart disease, and hypertension. The appeal seeking to readjudicate a claim for service connection for hypertension based on new evidence was dismissed as moot. Bilateral hearing loss will be readjudicated by the AOJ.

The Board denied service connection for hypertensive heart disease, erectile dysfunction, right and left lower extremity neuropathy, and bilateral hearing loss as there was no evidence of in-service exposure to herbicides or a nexus between the claimed disorders and service.